ResearcherLiaoning Cancer Hospital & InstituteNo recent work listed

Xin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2937-0625; OpenAlex author ID A5101814185. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 2 papers

Papers 2

LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p. Co-author DOI 10.1016/j.abb.2020.108469 ↗
TSPAN1 promotes human pancreatic cancer cells proliferation by modulating CDK1 via Akt Co-author DOI 10.1101/2020.05.29.123091 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiaxun Tian · 2 shared papers, 2020 · strength 0.25
- Paper LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p. DOI 10.1016/j.abb.2020.108469 ↗
- Paper TSPAN1 promotes human pancreatic cancer cells proliferation by modulating CDK1 via Akt DOI 10.1101/2020.05.29.123091 ↗
Xiangdong Hua · 2 shared papers, 2020 · strength 0.25
- Paper LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p. DOI 10.1016/j.abb.2020.108469 ↗
- Paper TSPAN1 promotes human pancreatic cancer cells proliferation by modulating CDK1 via Akt DOI 10.1101/2020.05.29.123091 ↗
Gang Shi · 2 shared papers, 2020 · strength 0.25
- Paper LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p. DOI 10.1016/j.abb.2020.108469 ↗
- Paper TSPAN1 promotes human pancreatic cancer cells proliferation by modulating CDK1 via Akt DOI 10.1101/2020.05.29.123091 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.